−0.0547USD
−15.18 MUSD
65.65 KUSD
63.50 M
About Navidea Biopharmaceuticals, Inc.
Sector
Industry
Headquarters
Dublin
Website
Employees (FY)
15
Founded
1983
FIGI
BBG000BCJ6W1
Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of NAVB is 0.0375 USD — it has increased by 1.90% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Navidea Biopharmaceuticals, Inc. stocks are traded under the ticker NAVB.
Navidea Biopharmaceuticals, Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
NAVB stock is 1.90% volatile and has beta coefficient of 0.04. Check out the list of the most volatile stocks — is Navidea Biopharmaceuticals, Inc. there?
NAVB earnings for the last quarter are −0.08 USD per share, whereas the estimation was −0.09 USD resulting in a 11.11% surprise. The estimated earnings for the next quarter are −0.03 USD per share. See more details about Navidea Biopharmaceuticals, Inc. earnings.
Navidea Biopharmaceuticals, Inc. revenue for the last quarter amounts to 96.38 K USD despite the estimated figure of 600.00 K USD. In the next quarter revenue is expected to reach 1.80 M USD.
Yes, you can track Navidea Biopharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
NAVB stock has risen by 4.17% compared to the previous week, the month change is a 8.54% fall, over the last year Navidea Biopharmaceuticals, Inc. has showed a 85.12% decrease.
NAVB net income for the last quarter is −2.26 M USD, while the quarter before that showed 6.03 M USD of net income which accounts for −137.39% change. Track more Navidea Biopharmaceuticals, Inc. financial stats to get the full picture.
Today Navidea Biopharmaceuticals, Inc. has the market capitalization of 3.68 M, it has increased by 28.65% over the last week.
No, NAVB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NAVB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Navidea Biopharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 15.00 employees. See our rating of the largest employees — is Navidea Biopharmaceuticals, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Navidea Biopharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Navidea Biopharmaceuticals, Inc. stock shows the sell signal. See more of Navidea Biopharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Navidea Biopharmaceuticals, Inc. EBITDA is −10.03 M USD, and current EBITDA margin is −21.09 K%. See more stats in Navidea Biopharmaceuticals, Inc. financial statements.